Teva's Barr Labs settles Cipro antitrust case for $225 mln

Jan 26 (Reuters) - Teva Pharmaceutical Industries Ltd's

Barr Laboratories Inc has reached a $225 million

settlement in an antitrust class action that accused the

drugmaker of keeping a generic version of Bayer AG's

antibiotic Cipro off the market, court documents showed.

Read more